Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase Deltex-1 (DTX1) is a member of the Deltex protein family and serves as an E3 ubiquitin ligase, a key enzyme responsible for transferring ubiquitin to specific substrates during protein ubiquitination. DTX1 is highly conserved evolutionarily and is expressed in both the cytoplasm and nucleus. DTX1 is a central regulator of the Notch signaling pathway in a variety of cell types, including immune cells where it modulates T and B cell development, apoptosis, and immune tolerance. DTX1 interacts with multiple signaling pathways—including PI3K/AKT and MAPK—and with downstream targets such as c-FLIP, MEKK1, HIF-1α, and transcription factors like HES1 and NFAT. Dysregulation or mutation of DTX1 has been linked to several malignancies, especially B cell lymphomas, where it may act as either a tumor suppressor or oncogene depending on cellular context. Its precise physiological and pathological mechanisms continue to be areas of active research, and it is being explored as a potential diagnostic and therapeutic target in cancer and immune-related disorders
No drugs directly target DTX1 in clinical use; inhibitors would theoretically modulate protein ubiquitination and Notch signaling, with downstream effects on cell differentiation, apoptosis, and immune responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase Deltex-1 (DTX1).